SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001725160-22-000115
Filing Date
2022-05-31
Accepted
2022-05-31 16:03:56
Documents
2

Document Format Files

Seq Description Document Type Size
1 DEFA14A zntl-defa14a2022annualmeet.htm DEFA14A 38308
2 image_0.jpg GRAPHIC 5180
  Complete submission text file 0001725160-22-000115.txt   46688
Mailing Address 1359 BROADWAY, SUITE 1710 NEW YORK NY 10018
Business Address 1359 BROADWAY, SUITE 1710 NEW YORK NY 10018 (212) 433-3791
Zentalis Pharmaceuticals, Inc. (Filer) CIK: 0001725160 (see all company filings)

IRS No.: 823607803 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-39263 | Film No.: 22983157
SIC: 2834 Pharmaceutical Preparations